Study Details

Back
Study ID 9785-CL-0111
Study Title A Phase 1-2, Open-Label, Uncontrolled, Dose-Escalation Study of MDV3100 in Patients with Castration-Resistant Prostate Cancer
Clinicaltrials.gov Identifier NCT01284920
Compound Name MDV3100 / enzalutamide
Medical Indication or Disease Prostate cancer
Study Sponsor Astellas Pharma Inc.
Collaborator Medivation, Inc.
Study Start Date 02-Nov-2010
Study Completion Date 02-Jul-2014
Clinical Study Result
Select the language
English
Plain Language Summary
Select the language
Japanese

QUICK SEARCH

USEFUL LINKS